Clostridium difficile infection (CDI) represents one of the most common healthcare-associated infections. Due to increasing numbers of recurrences and therapy failures, CDI has become a major disease burden. Studies have shown that fecal microbiota transplantation (FMT) can both be a safe and highly efficacious therapy for patients with therapy-refractory CDI. However, patients undergoing solid organ transplantation are at high risk for CDI due to long-term immunosuppression, previous antibiotic therapy, and proton pump inhibitor use. Additionally, these patients may be especially prone to adverse events related to FMT. Here, we report a successful FMT in a patient with severe therapy-refractory CDI after liver transplantation.
CITATION STYLE
Schneider, K. M., Wirtz, T. H., Kroy, D., Albers, S., Neumann, U. P., Strowig, T., … Trautwein, C. (2018, April 13). Successful Fecal Microbiota Transplantation in a Patient with Severe Complicated Clostridium difficile Infection after Liver Transplantation. Case Reports in Gastroenterology. S. Karger AG. https://doi.org/10.1159/000481937
Mendeley helps you to discover research relevant for your work.